학술논문

A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome
Document Type
Article
Source
In: Nature Communications. (Nature Communications, December 2024, 15(1))
Subject
Language
English
ISSN
20411723